Condition
Cancer Nos
Total Trials
4
Recruiting
0
Active
1
Completed
2
Success Rate
66.7%-20% vs avg
Key Insights
Highlights
Success Rate
67% trial completion
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 87/100
Termination Rate
25.0%
1 terminated out of 4 trials
Success Rate
66.7%
-19.8% vs benchmark
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
0 of 2 completed with results
Key Signals
67% success
Data Visualizations
Phase Distribution
3Total
Not Applicable (2)
P 1 (1)
Trial Status
Completed2
Active Not Recruiting1
Terminated1
Trial Success Rate
66.7%
Benchmark: 86.5%
Based on 2 completed trials
Clinical Trials (4)
Showing 4 of 4 trials
NCT03621124TerminatedPrimary
Maladaptive Adipose Tissue Activity in Cancer
NCT06926972Not ApplicableActive Not RecruitingPrimary
NutritiOUs fRuIts and veggieS to Improve Health: A Culinary Medicine Intervention
NCT03052868Not ApplicableCompletedPrimary
Analysis of Neurocognitive Elements of Attention After Chemotherapy
NCT01750580Phase 1CompletedPrimary
Safety Study of BMS-986015 (Anti-KIR) in Combination With Ipilimumab in Subjects With Selected Advanced Tumor
Showing all 4 trials